PortfoliosLab logoPortfoliosLab logo
IPO Date
Jan 3, 2023

Highlights

Total Revenue (TTM)
$7.83M
Gross Profit (TTM)
-$639.50K
EBITDA (TTM)
-$5.21M
Year Range
$0.00 - $0.16
ROA (TTM)
-8.01%
ROE (TTM)
-89.85%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

MLECW Performance Chart

Moolec Science SA Warrant (MLECW) is up 191.4% since the beginning of the year. At $0 per share, MLECW is trading 89.4% below its 52-week high of $0.


Loading charts...

S&P 500 Index

Returns By Period

Moolec Science SA Warrant (MLECW) has returned 191.38% so far this year and 76.04% over the past 12 months.


Moolec Science SA Warrant

1D
-7.65%
1M
-26.52%
YTD
191.38%
6M
39.67%
1Y
76.04%
3Y*
-39.89%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.68%
YTD
11.16%
6M
11.10%
1Y
27.46%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MLECW Monthly Returns History

Based on dividend-adjusted daily data since Jan 3, 2023, MLECW's average daily return is +1.22%, while the average monthly return is +11.32%. At this rate, an investment would double in approximately 0.5 years.

Historically, 45% of months were positive and 55% were negative. The best month was Feb 2026 with a return of +558.6%, while the worst month was Mar 2025 at -78.3%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.

On a daily basis, MLECW closed higher 26% of trading days. The best single day was Dec 26, 2024 with a return of +228.0%, while the worst single day was Mar 26, 2025 at -58.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202650.00%558.62%-54.97%-1.94%-24.90%-11.05%191.38%
202523.23%25.24%-78.32%98.82%-26.63%31.45%14.72%-43.85%2.86%18.52%-10.16%-49.57%-77.17%
202481.36%43.86%-51.05%87.54%13.85%-16.67%30.00%-46.00%13.96%-0.25%10.03%-42.14%15.45%
2023-28.62%33.42%-43.90%-18.98%-14.41%2.70%-13.39%-6.79%-45.58%-28.49%19.52%-26.67%-89.52%

Benchmark Metrics

Moolec Science SA Warrant has an annualized alpha of 1604.24%, beta of 1.06, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 04, 2023.

  • This stock participated in 204.97% of S&P 500 Index downside but only -94.52% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
1,604.24%
Beta
1.06
0.00
Upside Capture
-94.52%
Downside Capture
204.97%

Return for Risk

Risk / Return Rank

MLECW ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


MLECW Risk / Return Rank: 6161
Overall Rank
MLECW Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
MLECW Sortino Ratio Rank: 8585
Sortino Ratio Rank
MLECW Omega Ratio Rank: 8383
Omega Ratio Rank
MLECW Calmar Ratio Rank: 4848
Calmar Ratio Rank
MLECW Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Moolec Science SA Warrant (MLECW) and compare them to S&P 500 Index.


MLECWBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.08

2.39

-2.30

Sortino ratio

Return per unit of downside risk

2.76

3.25

-0.50

Omega ratio

Gain probability vs. loss probability

1.35

1.43

-0.09

Calmar ratio

Return relative to maximum drawdown

0.33

3.11

-2.78

Martin ratio

Return relative to average drawdown

0.57

14.38

-13.82

Dividends

Dividend History


Moolec Science SA Warrant doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Moolec Science SA Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Moolec Science SA Warrant was 97.82%, occurring on Jan 9, 2026. The portfolio has not yet recovered.

The current Moolec Science SA Warrant drawdown is 92.32%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-97.82%Jan 2026
2y 10mo
3y 3moFeb 2023 - now
2023 bear market2023
-46.00%Jan 2023
23d1mo 1d
1mo 24dJan 2023 - Feb 2023

Drawdown Indicators


MLECWBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-97.82%

-56.78%

-41.04%

Max Drawdown (1Y)

Largest decline over 1 year

-75.63%

-9.10%

-66.53%

Max Drawdown (3Y)

Largest decline over 3 years

-94.66%

-18.90%

-75.76%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-92.32%

0.00%

-92.32%

Average Drawdown

Average peak-to-trough decline

-79.42%

-10.72%

-68.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.67%

1.97%

+42.70%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Moolec Science SA Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Moolec Science SA Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with MLECW

Add Moolec Science SA Warrant to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with MLECW